Bgm BGM
NASDAQ BGM
$0.26 -0.02 (-7.52%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bgm (BGM) Liabilities and Shareholders Equity (2019 - 2025)

Bgm (BGM) posted quarterly Liabilities and Shareholders Equity of $433.8 million for Q3 2025, up 20485.23% year-over-year from N/an in Q3 2024, and up 109.17% quarter-over-quarter from $207.4 million in Q1 2025.

Bgm (BGM) Liabilities and Shareholders Equity (2019 - 2025) Analysis & Trends

Bgm (BGM) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $433.8 million the latest figure, recorded in Q3 2025.

  • In Q3 2025, Liabilities and Shareholders Equity rose 20485.23% year-over-year to $433.8 million; the TTM figure through Sep 2025 stood at $693.2 million (up 571.56% YoY), while the FY2025 annual figure was $433.8 million, up 20485.23% from the prior year.
  • Liabilities and Shareholders Equity grew to $433.8 million in Q3 2025 per BGM's latest filing, from $207.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $433.8 million in Q3 2025 and bottomed at $64.23 in Q1 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $88.4 million across 5 years, with a median of $50.6 million in 2023.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 77610725.48% in 2024 and fell as far as 95.89% in 2024.
  • Bgm's Liabilities and Shareholders Equity stood at $75.4 million in 2021, then retreated by 14.37% to $64.5 million in 2022, then slipped by 20.56% to $51.3 million in 2023, then slumped by 95.89% to $2.1 million in 2024, then surged by 20485.23% to $433.8 million in 2025.
  • Business Quant data shows BGM's Liabilities and Shareholders Equity at $433.8 million in Q3 2025, $207.4 million in Q1 2025, and $2.1 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 Bgm 30.61 Mn 20.79 Mn - 433.81 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 433.81 Mn
Mar 31, 2025 207.39 Mn
Sep 30, 2024 2.11 Mn
Mar 31, 2024 49.85 Mn
Sep 30, 2023 51.26 Mn
Mar 31, 2023 64.23
Sep 30, 2022 64.53 Mn
Mar 31, 2022 80.15
Sep 30, 2021 75.35 Mn
Mar 31, 2021 70.04
Sep 30, 2020 48.14 Mn
Sep 30, 2019 35.27 Mn